CIBC Private Wealth Group, LLC
- SEC CIK
- 0001298088
- Latest filing
- Feb 12, 2026
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by CIBC Private Wealth Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q4 2025 holdings
- Shares (Q4 2025)
- 2,288
- Value
- $154.0K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 2,288 | $154.0K | <0.1% | −603−20.9% | Reduced | Holders |
| Q3 2025 | 2,891 | $212.0K | <0.1% | +329+12.8% | Added | Holders |
| Q2 2025 | 2,562 | $133.3K | <0.1% | −1,484−36.7% | Reduced | Holders |
| Q1 2025 | 4,046 | $232.8K | <0.1% | +993+32.5% | Added | Holders |
| Q4 2024 | 3,053 | $164.1K | <0.1% | −963,451−99.7% | Reduced | Holders |
| Q3 2024 | 966,504 | $55.3M | 0.1% | +962,575+24,499.2% | Added | Holders |
| Q2 2024 | 3,929 | $206.5K | <0.1% | +1,046+36.3% | Added | Holders |
| Q1 2024 | 2,883 | $119.1K | <0.1% | +2,883 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −26,239−100.0% | Sold out | Holders |
| Q4 2022 | 26,239 | $1.49K | <0.1% | +26,239 | New | Holders |